Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 28 January, 2009 and appeared in  Issue 453MedicationType 2 Diabetes

Many Diabetes Patients Doubt The Benefits Of Their Diabetes Medications

Many people with type 2 diabetes may be skeptical about the safety and effectiveness of their medications, African Americans in particular, a new study suggests.

Advertisement

What's more, researchers found, study participants with the greatest safety concerns tended to underuse prescriptions for controlling blood sugar and blood pressure -- a fact that could raise their risk of diabetes complications.

The results suggest that doctors could do a better job discussing medication benefits and risks, the researchers report in the journal Diabetes Care.

Patients should be told to bring any concerns about potential drug side effects to their doctors.

Dr. Aikens of the University of Michigan, stated that, "If they do not, the physician will often assume that everything is working out fine, whereas the patient feels like the physician may be holding information back.

The findings are based on surveys of 806 diabetes patients, many of whom were low-income. More than half were African American. In general, the researchers found, many patients were concerned about the necessity or safety of their medications for controlling blood sugar or high blood pressure. Black patients were more likely than white patients to have safety worries.
The study also found that up to half of patients underused at least one of their medications. This was often because of costs, but patients who worried about medication safety were also more likely to skip doses.

While such concerns were more common among African Americans, they were also more often seen among patients who were dissatisfied with the information they'd received from their doctor, regardless of race.

That, the researchers say, suggests that better communication might ease some patients' worries -- and possibly boost their treatment adherence.

Aikens suggested that diabetes patients "get the ball rolling" by bringing a list of their treatment questions to their medical appointments and by clearly stating their concerns at the beginning of the visit.

Diabetes Care, January 2009

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 28 January, 2009 and appeared in  Issue 453MedicationType 2 Diabetes

Past five issues: Diabetes Clinical Mastery Series Issue 141 | Issue 681 | Diabetes Clinical Mastery Series Issue 140 | Issue 680 | Diabetes Clinical Mastery Series Issue 139 |

2013 Most Popular Articles:

Mortality Risk in Patients with Type 2 Diabetes
Posted May 23, 2013
Bacteria in the Gut Improves the Management of Obesity and Type 2 Diabetes
Posted May 23, 2013
Hypoglycemia Treatment and Prevention Related to Physical Activity
Posted May 31, 2013
Simvastatin Can Reduce the Benefits of Exercise in Active Adults
Posted May 23, 2013
Scientist Use Bone Marrow Stem Cells to Cure Type 1 Diabetes
Posted June 06, 2013
Diabetes Epidemic Growing
Posted May 23, 2013
Co-Q10 May Offset Risk of Diabetes with Statin Use
Posted May 23, 2013
Artificial Sweeteners May Affect Blood Glucose Levels and Insulin Response
Posted June 06, 2013
Diabetes Increases Cancer Risk by 20 Percent
Posted May 16, 2013
Pros and Cons of Incretin-Based Therapies
Posted May 30, 2013

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control



Search Articles On Diabetes In Control